Navelbine 30 (Vinorelbine Tartrate Capsule) 30mg

Navelbine 30 (Vinorelbine Tartrate) 30mg capsules are prescribed for cancer treatment, including lung and breast cancers. This chemotherapy agent works by slowing or stopping cancer cell growth. Always store between 2-8°C and follow healthcare provider instructions.

Strength

30mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Robapharm Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Navelbine 30 is used to treat certain types of cancer, such as non-small cell lung cancer and metastatic breast cancer. It may be prescribed when other treatments are not suitable or have not worked. This medication helps control cancer progression by interfering with cancer cell division. Patients often ask, 'what is Navelbine 30 used for' to understand its role in their treatment plan.

Side Effects

Navelbine 30 may cause mild to moderate side effects, including nausea, fatigue, or constipation. Some patients experience temporary hair thinning rather than complete hair loss. These effects vary by individual and are typically monitored by a healthcare professional. Most side effects are manageable with supportive care.

Precautions & Warnings

Keep Navelbine 30 capsules refrigerated between 2-8°C and protect from light. Handle with care to avoid accidental exposure; wear gloves if handling broken capsules. Do not open or crush capsules unless instructed. Always follow your doctor’s storage and handling guidelines to maintain medication integrity.

Avoid Interactions

Navelbine 30 may interact with other medications, including certain antifungals, antibiotics, or HIV treatments. Strong CYP3A4 inhibitors can increase vinorelbine levels, while inducers may reduce effectiveness. Avoid grapefruit products unless approved by your doctor. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Navelbine 30 is used to treat certain cancers like non-small cell lung cancer and metastatic breast cancer.

Store Navelbine 30 capsules refrigerated between 2-8°C and protect from light.

Do not open or crush Navelbine 30 capsules unless instructed by your healthcare provider.

Common side effects may include nausea, fatigue, or constipation.

Yes, it may interact with strong CYP3A4 inhibitors or inducers; consult your doctor before combining.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.